Pyxis Oncology (PYXS) Profit After Tax (QoQ) (2020 - 2025)
Pyxis Oncology (PYXS) Profit After Tax (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Pyxis Oncology | 182.39 Mn | 115.53 Mn | 8.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.89% |
| Sep 30, 2025 | -19.48% |
| Jun 30, 2025 | 13.25% |
| Mar 31, 2025 | 40.95% |
| Dec 31, 2024 | -72.67% |
| Sep 30, 2024 | -19.94% |
| Jun 30, 2024 | -431.36% |
| Mar 31, 2024 | 79.04% |
| Dec 31, 2023 | 32.60% |
| Sep 30, 2023 | -38.17% |
| Jun 30, 2023 | 13.31% |
| Mar 31, 2023 | 46.67% |
| Dec 31, 2022 | -30.39% |
| Sep 30, 2022 | -8.26% |
| Jun 30, 2022 | 18.54% |
| Mar 31, 2022 | -86.19% |
| Dec 31, 2021 | -18.90% |
| Sep 30, 2021 | -74.01% |
| Jun 30, 2021 | 77.88% |
| Mar 31, 2021 | -695.70% |